Title: Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
Journal: Handbook of experimental pharmacology20170101
Title: The molecular targets of approved treatments for pulmonary arterial hypertension.
Journal: Thorax20160101
Title: Riociguat for the treatment of pulmonary hypertension.
Journal: Expert review of respiratory medicine20150101
Title: Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Journal: P & T : a peer-reviewed journal for formulary management20141101
Title: Riociguat: first global approval.
Journal: Drugs20131101
Title: Pathways in pulmonary arterial hypertension: the future is here.
Journal: European respiratory review : an official journal of the European Respiratory Society20121201
Title: Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design.
Journal: European journal of heart failure20120801
Title: BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes.
Journal: British journal of pharmacology20120701
Title: Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.
Journal: Critical care research and practice20120101
Title: Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade.
Journal: PloS one20120101
Title: The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
Journal: PloS one20120101
Title: cGMP Signaling, Phosphodiesterases and Major Depressive Disorder.
Journal: Current neuropharmacology20111201
Title: NOX1, 2, 4, 5: counting out oxidative stress.
Journal: British journal of pharmacology20111001
Title: Riociguat (BAY 63-2521) and warfarin: a pharmacodynamic and pharmacokinetic interaction study.
Journal: Journal of clinical pharmacology20110701
Title: New perspectives for the treatment of pulmonary hypertension.
Journal: British journal of pharmacology20110501
Title: Riociguat for the treatment of pulmonary hypertension.
Journal: Expert opinion on investigational drugs20110401
Title: Soluble guanylate cyclase modulators in heart failure.
Journal: Current heart failure reports20110301
Title: Recent trends in pulmonary arterial hypertension.
Journal: Lung India : official organ of Indian Chest Society20110101
Title: Therapeutic strategies in pulmonary hypertension.
Journal: Frontiers in pharmacology20110101
Title: Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats.
Journal: PloS one20110101
Title: Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
Journal: PloS one20110101
Title: Overview of current therapeutic approaches for pulmonary hypertension.
Journal: Pulmonary circulation20110101
Title: Lung transplantation for pulmonary hypertension.
Journal: Pulmonary circulation20110101
Title: Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study.
Journal: The European respiratory journal20101001
Title: Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
Journal: Journal of hypertension20100801
Title: [Pulmonary arterial hypertension--a rare form of pulmonary hypertension].
Journal: Deutsche medizinische Wochenschrift (1946)20100501
Title: Riociguat for pulmonary hypertension.
Journal: Future cardiology20100301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20100301
Title: Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
Journal: European respiratory review : an official journal of the European Respiratory Society20100301
Title: Animal models related to congenital heart disease and clinical research in pulmonary hypertension.
Journal: Cardiology20100101
Title: Translating the oxidative stress hypothesis into the clinic: NOX versus NOS.
Journal: Journal of molecular medicine (Berlin, Germany)20091101
Title: Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
Journal: Current opinion in investigational drugs (London, England : 2000)20090901
Title: Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension.
Journal: ChemMedChem20090501
Title: First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension.
Journal: The European respiratory journal20090401
Title: Molecule of the month. Riociguat.
Journal: Drug news & perspectives20090401
Title: Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy.
Journal: European respiratory review : an official journal of the European Respiratory Society20090301
Title: NO-independent, haem-dependent soluble guanylate cyclase stimulators.
Journal: Handbook of experimental pharmacology20090101
Title: Pulmonary arterial hypertension: on the way to a manageable disease.
Journal: Current opinion in investigational drugs (London, England : 2000)20080901
Title: NO-independent regulatory site on soluble guanylate cyclase.
Journal: Nature20010308
